Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Richardson, Barbra"" wg kryterium: Autor


Wyświetlanie 1-15 z 15
Tytuł:
Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus.
Autorzy:
Yucha R; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Litchford ML; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Fish CS; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Yaffe ZA; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA.; Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA.
Richardson BA; Department of Global Health, University of Washington, Seattle, WA 98195, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Maleche-Obimbo E; Department of Pediatrics and Child Health, University of Nairobi, Nairobi P.O. Box 30197, Kenya.
John-Stewart G; Department of Global Health, University of Washington, Seattle, WA 98195, USA.; Department of Medicine, University of Washington, Seattle, WA 98195, USA.; Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.; Department of Epidemiology, University of Washington, Seattle, WA 98195, USA.
Wamalwa D; Department of Global Health, University of Washington, Seattle, WA 98195, USA.; Department of Pediatrics and Child Health, University of Nairobi, Nairobi P.O. Box 30197, Kenya.
Overbaugh J; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Lehman DA; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Oct 06; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HIV-1*/genetics
HIV Infections*
Child ; Humans ; Proviruses/genetics ; Kenya ; CD4-Positive T-Lymphocytes ; Antibody-Dependent Cell Cytotoxicity
Czasopismo naukowe
Tytuł:
Higher prevalence of viral control in HIV-1-infected women in serodiscordant relationships.
Autorzy:
Peebles K; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
McClelland RS; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Overbaugh J; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Richardson BA; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Bosire R; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Centre for Public Health Research, Kenya Medical Research Institute, Nairobi, Kenya.
Kiarie JN; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
Farquhar C; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America.
Guthrie BL; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Dec 05; Vol. 13 (12), pp. e0208401. Date of Electronic Publication: 2018 Dec 05 (Print Publication: 2018).
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*epidemiology
HIV Seropositivity/*epidemiology
HIV-1/*physiology
Sex Workers/*statistics & numerical data
Adult ; Cohort Studies ; Female ; HIV Infections/virology ; HIV Seropositivity/virology ; HIV-1/genetics ; Humans ; Kenya/epidemiology ; Poisson Distribution ; Prevalence ; RNA, Viral/genetics ; Viral Load ; Young Adult
Czasopismo naukowe
Tytuł:
High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.
Autorzy:
Liu AY; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
De Rosa SC; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Guthrie BL; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Choi RY; Department of Medicine, University of Washington, Seattle, Washington, USA.
Kerubo-Bosire R; Centre for Public Health Research, Kenya Medical Research Institute, Nairobi, Kenya.
Richardson BA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Kiarie J; Department of Obstetrics and Gynaecology, Kenyatta National Hospital, Nairobi, Kenya.
Farquhar C; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Lohman-Payne B; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2018 Sep; Vol. 6 (3), pp. 392-401. Date of Electronic Publication: 2018 Jul 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HIV-1*
CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
HIV Seronegativity/*immunology
Interferon-gamma/*immunology
ADP-ribosyl Cyclase 1/immunology ; Adult ; Cities ; Enzyme-Linked Immunospot Assay ; Female ; HLA-DR Antigens/immunology ; Humans ; Kenya ; Lymphocyte Activation ; Male ; Membrane Glycoproteins/immunology ; Young Adult
Czasopismo naukowe
Tytuł:
Role of p16 testing in cervical cancer screening among HIV-infected women.
Autorzy:
McGrath CJ; Department of Global Health, University of Washington, Seattle, Washington United States of America.
Garcia R; Department of Pathology, University of Washington, Seattle, Washington, United States of America.
Trinh TT; Department of Global Health, University of Washington, Seattle, Washington United States of America.
Richardson BA; Department of Global Health, University of Washington, Seattle, Washington United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.; Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
John-Stewart GC; Department of Global Health, University of Washington, Seattle, Washington United States of America.; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Nyongesa-Malava E; Kenyatta National Hospital, Nairobi, Kenya.
Mugo NR; Kenyatta National Hospital, Nairobi, Kenya.
Glynn EH; Department of Pathology, University of Washington, Seattle, Washington, United States of America.
Sakr SR; Coptic Hospital, Nairobi, Kenya.
De Vuyst H; International Agency for Research on Cancer, Lyon, France.
Chung MH; Department of Global Health, University of Washington, Seattle, Washington United States of America.; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Oct 12; Vol. 12 (10), pp. e0185597. Date of Electronic Publication: 2017 Oct 12 (Print Publication: 2017).
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
HIV-1*
HIV Infections/*diagnosis
HIV Protease/*metabolism
Uterine Cervical Neoplasms/*diagnosis
Uterine Cervical Neoplasms/*epidemiology
Adolescent ; Adult ; Female ; HIV Infections/metabolism ; HIV Infections/pathology ; Humans ; Immunohistochemistry/methods ; Kenya ; Mass Screening/methods ; Middle Aged ; Papanicolaou Test/methods ; Uterine Cervical Neoplasms/metabolism ; Uterine Cervical Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial.
Autorzy:
Polyak CS; US Military HIV Research Program, Walter Reed Army Institute of Research, Bethesda, Maryland, United States of America.; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Yuhas K; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Singa B; Kenya Medical Research Institute, Nairobi, Kenya.
Khaemba M; Kenya Medical Research Institute, Nairobi, Kenya.
Walson J; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.
Richardson BA; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
John-Stewart G; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2016 Jan 05; Vol. 13 (1), pp. e1001934. Date of Electronic Publication: 2016 Jan 05 (Print Publication: 2016).
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
HIV-1*
Post-Exposure Prophylaxis*/methods
Anti-Retroviral Agents/*administration & dosage
HIV Infections/*epidemiology
Malaria/*epidemiology
Sulfadoxine/*administration & dosage
Trimethoprim/*administration & dosage
Adult ; Antimalarials/administration & dosage ; Drug Combinations ; Female ; HIV Infections/diagnosis ; HIV Infections/drug therapy ; Humans ; Kenya/epidemiology ; Malaria/diagnosis ; Malaria/prevention & control ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Mode of delivery and postpartum HIV-1 disease progression and mortality in a Kenyan cohort.
Autorzy:
Unger JA; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA. .
Richardson BA
Otieno PA
Farquhar C
Wamalwa D
John-Stewart GC
Pokaż więcej
Źródło:
BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2014 Aug 03; Vol. 14, pp. 257. Date of Electronic Publication: 2014 Aug 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Cesarean Section*
HIV Infections/*immunology
HIV Infections/*mortality
HIV-1/*immunology
Adult ; Anti-HIV Agents/therapeutic use ; CD4 Lymphocyte Count ; Cause of Death ; Disease Progression ; Emergencies ; Female ; HIV Infections/drug therapy ; HIV-1/genetics ; Humans ; Kenya/epidemiology ; Maternal Mortality ; Parturition ; Postpartum Period ; Prospective Studies ; RNA, Viral/blood ; Young Adult ; Zidovudine/therapeutic use
Czasopismo naukowe
Tytuł:
HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.
Autorzy:
Seaton KE; Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Ballweber L; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, United States of America.
Lan A; Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Donathan M; Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Hughes S; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, United States of America.
Vojtech L; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, United States of America.
Moody MA; Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Liao HX; Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Haynes BF; Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Galloway CG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Richardson BA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Karim SA; CAPRISA - Centre for the AIDS Programme of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa; Department of Epidemiology, Columbia University, New York, New York, United States of America.
Dezzutti CS; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Tomaras GD; Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Hladik F; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, United States of America; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Jul 23; Vol. 9 (7), pp. e101863. Date of Electronic Publication: 2014 Jul 23 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Envelope Protein gp120/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Immunoglobulin A/*immunology
env Gene Products, Human Immunodeficiency Virus/*immunology
Analysis of Variance ; Anti-Infective Agents/immunology ; Anti-Infective Agents/therapeutic use ; Bodily Secretions/immunology ; Bodily Secretions/virology ; Cohort Studies ; Female ; HIV Antibodies/immunology ; HIV Infections/diagnosis ; HIV Infections/prevention & control ; HIV Seronegativity/immunology ; HIV Seropositivity/immunology ; HIV-1/drug effects ; Humans ; Immunity, Mucosal/drug effects ; Immunity, Mucosal/immunology ; Immunoglobulin G/immunology ; Pilot Projects ; South Africa ; Specimen Handling/instrumentation ; Specimen Handling/methods ; Vagina/immunology ; Vagina/virology
Czasopismo naukowe
Tytuł:
Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants.
Autorzy:
Slyker JA; Department of Global Health, University of Washington, Harborview Medical Center, 325 9th Ave, Box 359931, Seattle, WA 98104, USA. .
Patterson J
Ambler G
Richardson BA
Maleche-Obimbo E
Bosire R
Mbori-Ngacha D
Farquhar C
John-Stewart G
Pokaż więcej
Źródło:
BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2014 Jan 08; Vol. 14, pp. 7. Date of Electronic Publication: 2014 Jan 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*
Cervix Uteri/*chemistry
HIV Infections/*epidemiology
Pregnancy Complications, Infectious/*epidemiology
Premature Birth/*epidemiology
RNA, Viral/*blood
Adult ; Birth Weight ; Body Mass Index ; Cervix Uteri/cytology ; Female ; HIV Infections/blood ; HIV Infections/virology ; Humans ; Infant ; Infant Mortality ; Infant, Low Birth Weight ; Infant, Newborn ; Infant, Premature ; Infant, Small for Gestational Age ; Neutrophils ; Parity ; Pregnancy ; Pregnancy Complications, Infectious/blood ; Pregnancy Complications, Infectious/virology ; RNA, Viral/analysis ; Retrospective Studies ; Risk Factors ; Vaginal Discharge/epidemiology ; Vaginosis, Bacterial/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
HIV-1 superinfection occurs less frequently than initial infection in a cohort of high-risk Kenyan women.
Autorzy:
Ronen K; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
McCoy CO
Matsen FA
Boyd DF
Emery S
Odem-Davis K
Jaoko W
Mandaliya K
McClelland RS
Richardson BA
Overbaugh J
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2013; Vol. 9 (8), pp. e1003593. Date of Electronic Publication: 2013 Aug 29.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections/*epidemiology
HIV Infections/*immunology
HIV-1/*immunology
Superinfection/*epidemiology
Superinfection/*immunology
Adult ; Cohort Studies ; Female ; HIV Infections/genetics ; HIV-1/genetics ; Humans ; Incidence ; Kenya/epidemiology ; Superinfection/genetics ; Time Factors
Czasopismo naukowe
Tytuł:
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Autorzy:
Roxby AC; Department of Medicine, University of Washington, Seattle, Washington, United States of America. />Drake AL
Ongecha-Owuor F
Kiarie JN
Richardson B
Matemo DN
Overbaugh J
Emery S
John-Stewart GC
Wald A
Farquhar C
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (6), pp. e38622. Date of Electronic Publication: 2012 Jun 12.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*
Herpesvirus 2, Human*
Acyclovir/*analogs & derivatives
Antiviral Agents/*pharmacology
HIV Infections/*drug therapy
Herpes Genitalis/*drug therapy
Postpartum Period/*drug effects
Valine/*analogs & derivatives
Acyclovir/pharmacology ; Acyclovir/therapeutic use ; Antiviral Agents/therapeutic use ; Biomarkers/blood ; CD4 Antigens/blood ; Disease Progression ; Female ; Humans ; Kenya ; Linear Models ; Nevirapine/administration & dosage ; Pregnancy ; RNA, Viral/blood ; Valacyclovir ; Valine/pharmacology ; Valine/therapeutic use ; Zidovudine/administration & dosage
Czasopismo naukowe
Tytuł:
Prevalence and correlates of insecticide-treated bednet use among HIV-1-infected adults in Kenya.
Autorzy:
Nnedu ON; Department of Medicine, Section Infectious Diseases, Tulane University, New Orleans, LA, USA. />John-Stewart GC
Singa BO
Piper B
Otieno PA
Guidry A
Richardson BA
Walson J
Pokaż więcej
Źródło:
AIDS care [AIDS Care] 2012; Vol. 24 (12), pp. 1559-64. Date of Electronic Publication: 2012 Apr 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*
HIV Infections/*epidemiology
Insecticide-Treated Bednets/*statistics & numerical data
Malaria/*prevention & control
Adolescent ; Adult ; Aged ; Cross-Sectional Studies ; Female ; HIV Infections/diagnosis ; Humans ; Kenya/epidemiology ; Logistic Models ; Malaria/epidemiology ; Male ; Middle Aged ; Multivariate Analysis ; Prevalence ; Socioeconomic Factors ; Surveys and Questionnaires ; Young Adult
Czasopismo naukowe
Tytuł:
A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.
Autorzy:
Masese LN; Department of Epidemiology, Box 357236, University of Washington, Seattle, Washington 98195, USA. />Graham SM
Gitau R
Peshu N
Jaoko W
Ndinya-Achola JO
Mandaliya K
Richardson BA
Overbaugh J
McClelland RS
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2011 Nov 03; Vol. 11, pp. 307. Date of Electronic Publication: 2011 Nov 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Virus Shedding*
Anti-HIV Agents/*administration & dosage
HIV Infections/*complications
HIV-1/*isolation & purification
Trichomonas Vaginitis/*epidemiology
Trichomonas vaginalis/*isolation & purification
Vagina/*virology
Adolescent ; Adult ; Antiprotozoal Agents/administration & dosage ; Antiretroviral Therapy, Highly Active ; Cohort Studies ; Female ; HIV Infections/drug therapy ; Humans ; Kenya/epidemiology ; Metronidazole/administration & dosage ; Middle Aged ; Prospective Studies ; RNA, Viral/isolation & purification ; Trichomonas Vaginitis/parasitology ; Viral Load ; Young Adult
Czasopismo naukowe
Tytuł:
A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.
Autorzy:
Chung MH; Department of Global Health, University of Washington, Seattle, Washington, USA. />Richardson BA
Tapia K
Benki-Nugent S
Kiarie JN
Simoni JM
Overbaugh J
Attwa M
John-Stewart GC
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2011 Mar; Vol. 8 (3), pp. e1000422. Date of Electronic Publication: 2011 Mar 01.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Counseling*
Patient Compliance*
Reminder Systems*
Anti-Retroviral Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
HIV-1/*drug effects
Adult ; Anti-Retroviral Agents/pharmacology ; CD4 Lymphocyte Count ; Drug Combinations ; Female ; HIV Infections/mortality ; Humans ; Kenya ; Male ; Memory ; Proportional Hazards Models ; RNA, Viral/blood ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Higher pre-infection vitamin E levels are associated with higher mortality in HIV-1-infected Kenyan women: a prospective study.
Autorzy:
Graham SM; Department of Medicine, University of Washington, Seattle, Washington 98195, USA. />Baeten JM
Richardson BA
Bankson DD
Lavreys L
Ndinya-Achola JO
Mandaliya K
Overbaugh J
McClelland RS
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2007 Jun 26; Vol. 7, pp. 63. Date of Electronic Publication: 2007 Jun 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Viral Load*
HIV Infections/*blood
HIV Infections/*mortality
HIV-1/*pathogenicity
Vitamin E/*blood
Adult ; CD4 Lymphocyte Count ; Female ; HIV Infections/metabolism ; Humans ; Kenya/epidemiology ; Prospective Studies ; Survival Analysis ; Vitamin E Deficiency/virology
Czasopismo naukowe
    Wyświetlanie 1-15 z 15

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies